Barrington Research Reiterates Market Perform Rating for Cross Country Healthcare (NASDAQ:CCRN)

Barrington Research reiterated their market perform rating on shares of Cross Country Healthcare (NASDAQ:CCRN) in a research note published on Tuesday morning,Benzinga reports. They currently have a $18.61 target price on the business services provider’s stock. Barrington Research also issued estimates for Cross Country Healthcare’s Q2 2025 earnings at $0.04 EPS, Q3 2025 earnings at $0.06 EPS, Q4 2025 earnings at $0.09 EPS and FY2025 earnings at $0.26 EPS.

A number of other analysts have also weighed in on the company. Wall Street Zen began coverage on Cross Country Healthcare in a research report on Thursday, May 15th. They set a “hold” rating on the stock. UBS Group decreased their target price on Cross Country Healthcare from $18.61 to $16.50 and set a “neutral” rating for the company in a report on Tuesday, May 13th. Seven research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $17.93.

Cross Country Healthcare Price Performance

Shares of Cross Country Healthcare stock opened at $14.25 on Tuesday. The stock has a market capitalization of $467.12 million, a price-to-earnings ratio of -26.89, a price-to-earnings-growth ratio of 4.37 and a beta of 0.37. The business has a 50-day moving average of $13.70 and a 200 day moving average of $15.90. Cross Country Healthcare has a 12 month low of $9.58 and a 12 month high of $18.50.

Cross Country Healthcare (NASDAQ:CCRN) last posted its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.06 EPS for the quarter, beating the consensus estimate of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 1.41% and a positive return on equity of 2.56%. The company’s revenue was down 22.6% on a year-over-year basis. During the same period last year, the business earned $0.19 earnings per share. Equities research analysts anticipate that Cross Country Healthcare will post 0.53 earnings per share for the current year.

Institutional Investors Weigh In On Cross Country Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of CCRN. Quadrant Capital Group LLC purchased a new position in Cross Country Healthcare in the fourth quarter valued at $25,000. Plato Investment Management Ltd acquired a new position in shares of Cross Country Healthcare during the 4th quarter worth about $46,000. Longfellow Investment Management Co. LLC acquired a new position in shares of Cross Country Healthcare during the 1st quarter worth about $59,000. AlphaQuest LLC increased its holdings in shares of Cross Country Healthcare by 324.6% in the 1st quarter. AlphaQuest LLC now owns 8,297 shares of the business services provider’s stock valued at $124,000 after acquiring an additional 6,343 shares during the last quarter. Finally, Mint Tower Capital Management B.V. acquired a new stake in shares of Cross Country Healthcare during the 4th quarter worth about $182,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.